Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02083341
Other study ID # VVT-01
Secondary ID AHSC AFP Innovat
Status Completed
Phase N/A
First received
Last updated
Start date August 2014
Est. completion date January 15, 2016

Study information

Verified date September 2018
Source St. Michael's Hospital, Toronto
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Muscle tension dysphonia (MTD) is a disabling voice disorder which causes severe voice change, neck pain, and voice fatigue. Current therapy modalities to treat these disorders include multiple visits to a qualified speech language pathologist (SLP) for rehabilitation with voice exercises and focused laryngeal/neck massage. Access to these services is difficult with long waitlists and often not covered by current public health insurance or locally available to many patients in Ontario. The goal of this study is to demonstrate a reduction in symptoms and improvement in vocal function by applying an external vibration device to key sites (e.g. jaw, neck, skull base) commonly identified as a source of abnormal muscle tension and injury in certain voice disorders, specifically MTD.

This study will also investigate the effect of external vibration on the voice quality in classically trained singers (CTSs). Certain desirable acoustic qualities in a singers' voice are only accessible when the larynx and its extrinsic muscles are in a relaxed state. Muscle misuse and vocal strain are common problems in performers, which can result in conditions that require surgery and speech therapy, and may lead to a loss of income. Similar to vocal warm up exercises which contribute to the prevention of vocal injury, external vibration is expected to improve muscle perfusion in an acute setting and may have a direct effect on vocal fold cover viscosity.

Both study groups will be randomized to receive either the external vibration device or a sham device. The sham device looks identical to the experimental device but has the vibration component removed.


Description:

Muscle tension dysphonia is primarily treated with voice therapy with a qualified SLP. One of the key therapy tools for MTD is laryngeal extrinsic muscle massage along with voice and respiratory exercises. Access to these specialized services is difficult due to limited expertise and travel distance. The goal of this study is to demonstrate a reduction in symptoms and improvement in vocal function by applying an external vibration device to key sites (e.g. jaw, neck, skull base) commonly identified as a source of abnormal muscle tension and injury in certain voice disorders, specifically MTD. If the study shows a demonstrable benefit, patients would be trained to self administer the treatment along with a home program of therapy exercises. This novel therapy would improve delivery of care and allow speech therapy services to be more widely accessible with reduced number of therapy sessions required. The potential long term effects would be to decrease wait times to access these specialized services and lessen the need for return visits due to symptom recurrence.

The second part of this study is to investigate the effect of external vibration on the voice quality in CTSs. Certain desirable acoustic qualities in a singers' voice are only accessible when the larynx and its extrinsic muscles are in a relaxed state. Muscle misuse and vocal strain are common problems in performers, which can result in conditions that require surgery and speech therapy, and may lead to a loss of income. Similar to vocal warm up exercises which contribute to the prevention of vocal injury, external vibration is expected to improve muscle perfusion in an acute setting and may have a direct effect on vocal fold cover viscosity.


Recruitment information / eligibility

Status Completed
Enrollment 29
Est. completion date January 15, 2016
Est. primary completion date January 15, 2016
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility MTD Inclusion Criteria:

- Diagnosed with primary MTD

MTD Exclusion Criteria:

- Active smoker

- Currently receiving voice therapy from a SLP

- Currently receiving botox injections

- Past laryngeal surgery

CTS Inclusion Criteria:

- Professional or semi-professional classical singer

- Third year university performance major or greater CTS Exclusion Criteria

- Active smoker

- Known voice disorders

- Past laryngeal surgery

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Lelo® Siri vibrator
external vibration device
Lelo® Siri vibrator with vibration component removed
external vibration device - sham

Locations

Country Name City State
Canada St. Michael's Hospital Toronto Ontario

Sponsors (1)

Lead Sponsor Collaborator
St. Michael's Hospital, Toronto

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary jitter acoustic measurement from voice recordings measured at beginning and end of 1 hour study visit (before and after external vibration therapy)
Secondary shimmer acoustic measurement from voice recordings measured at beginning and end of 1 hour study visit (before and after external vibration therapy)
Secondary signal to noise ratio acoustic measurement from voice recordings measured at beginning and end of 1 hour study visit (before and after external vibration therapy)
Secondary fundamental frequency acoustic measurement from voice recordings measured at beginning and end of 1 hour study visit (before and after external vibration therapy)
Secondary singing power ratio (singer group only) acoustic measurement from voice recordings; captured for the singer group only measured at beginning and end of 1 hour study visit (before and after external vibration therapy)
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04713033 - Computational Cranial and Cervical Muscle Network in Normal and Disordered Voice N/A
Not yet recruiting NCT02724761 - Prophylactic Racemic Epinephrine in Anterior Cervical Discectomy and Fusion N/A
Recruiting NCT04584658 - Dysphagia and Dysphonia Outcomes in SARS CoV-2 (COVID-19) Infection (DYADS Study)
Not yet recruiting NCT03692494 - The Effects of Adding Expiratory Muscle Strength Training in Voice Therapy N/A
Recruiting NCT01017055 - Voice and Swallowing Outcomes Following Revision Anterior Cervical Spine Surgery
Recruiting NCT03720301 - The Use of Osteopathic Medical Manipulation to Decrease the Incidence and Severity of Post-Operative Sore Throat N/A
Completed NCT03240042 - Initial Increase in Cuff Pressure in Anterior Cervical Spinal Surgery N/A
Completed NCT02922309 - Comparing Telepractice and Conventional Face-to-face Voice Therapy N/A
Not yet recruiting NCT05479643 - A Personalized Voice Restoration Device for Patients With Laryngectomy N/A
Completed NCT05383417 - No Post Intubation Laryngeal Symptoms N/A
Completed NCT04591769 - Tracheal Tube Cuff Shape and Pressure N/A
Recruiting NCT06124053 - Investigation of the Effectiveness of Group Voice Therapy in Children N/A
Recruiting NCT05237648 - Assessing the Effects of Patient Self-Rating of Voice Quality on Voice Therapy Attendance and Outcomes N/A
Recruiting NCT05754606 - Artificial Intelligence and Benign Lesions of Vocal Folds Recognition
Not yet recruiting NCT03261141 - Correlation Between (PV-RQOL), The Auditory Perceptual Assessment and Acoustic Analysis of Voice in Dysphonic Children N/A
Recruiting NCT05110417 - Reversal of Botulinum Neurotoxin Injection Related Dysphonia With Pyridostigmine Phase 4
Recruiting NCT04290182 - A Study of Local Administration of Autologous Mesenchymal Stromal Cells in Dysphonic Patients With Vocal Fold Scarring Phase 1/Phase 2
Completed NCT03129880 - Intensive Versus Traditional Voice Therapy N/A
Active, not recruiting NCT05264961 - Behavioral Abnormalities in Dysphonic Children N/A
Completed NCT05410756 - Relationship Between Dysphonia And Anxiety In Fibromyalgia